reference/30229352

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30229352

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	3013
issn	0732-183X 1527-7755
issueIdentifier	18
pageRange	3007-3013
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3007
bibliographicCitation	Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, Flores R, Friedberg JS, Pisters K, Monberg M, Obasaju CK, Vogelzang NJ. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009 Jun 20;27(18):3007–13. PMID: 19364962; PMCID: PMC3646305.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5244efbd56aa6e190931b0b5a28e2446 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2345-6900 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c3b73755ef2d5ae305b36cd06c00e01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbd1730d983862958461d9d590e141c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b52e34f9349a5bc7fb9f45e5cc5153a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30f309a8835cdd87bc5c714fc74118e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7375ec4b53d32a4b6f612a94789db348 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2024c5b9609dd8d6491986edcc11c6a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e9c6715369b718c156e4f8b06ee7b8e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b65b312652d21187d3c0d5ee5896f4e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8752c42898cba9e0180fe47a475fd2f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12f5d61eb0f35a3148b86e10fc73c234 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d436714a0168b28418c18ea736c30e5
date	2009-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3646305 https://pubmed.ncbi.nlm.nih.gov/19364962 https://doi.org/10.1200/jco.2008.20.3943
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma
discusses	http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0004505
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D011013 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D010997Q000628 http://id.nlm.nih.gov/mesh/D008654Q000628 http://id.nlm.nih.gov/mesh/D002945Q000008 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D005971Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D010997Q000401 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D008654Q000532 http://id.nlm.nih.gov/mesh/D010997Q000532 http://id.nlm.nih.gov/mesh/D008654Q000401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D000068437
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6761 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851

Total number of triples: 65.